S 2329 — Emerging Pathogen Preparedness Program Authorization Act
Last action — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 118th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Emerging Pathogen Preparedness Program Authorization ActThis bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.
Bill Text
- Introduced Introduced in Senate Current html July 13, 2023
Action History
-
Introduced in Senate
-
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
- John W. Hickenlooper · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
- Hickenlooper, John W. Democratic
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S 2329 do?
- Emerging Pathogen Preparedness Program Authorization ActThis bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.
- Who sponsors S 2329?
- S 2329 is sponsored by Hickenlooper, John W. (Democratic).
- What is the current status of S 2329?
- This bill died with 118th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track S 2329?
- Track S 2329 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S 2329
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S 2329
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →